semaglutide for obesity monroe Another Weight-Loss Trial Win Weekly GLP-1 Drug Semaglutide for Weight Loss: Effective,

So, what makes Ozempic stand out

Wegovy consistently demonstrates greater weight loss than Trulicity

It is administered via a weekly subcutaneous injection

Good candidates usually have either: A BMI of 30 or more (indicating obesity) A BMI of 27 or more (indicating overweight) coupled with a weight-related medical condition such as high blood pressure or type 2 diabetes An aversion to injectables, preferring a daily pill Notably, oral semaglutide for weight loss in non-diabetics is an approved use, so a diabetes diagnosis isn't necessary

Brandt F, Thvilum M, Almind D, Christensen K, Green A, Hegedus L, et al

Laparoscopic and endoscopic pyloroplasty for gastroparesis results in sustained symptom improvement